Louis J. DeGennaro, Ph.D.
President and CEO
More than 25 years of research and drug development, and recognized as the key architect of LLS's cures and access agenda.
Lee Greenberger, Ph.D.,
Chief Scientific Officer
Over 25 years of experience in discovery and development of Oncology drugs. Leads planning and strategy for LLS research programs.
Gwen Nichols, MD,
Chief Medical Officer
A hematologist and scientific researcher, Nichols oversees LLS’s scientific research portfolio, patient services and policy and advocacy initiatives.
